The same dual role has been observed and reported in this review article in other PDEs including PDE1, PDE2, PDE4, and PDE7 that could complicate therapeutic development and underscores the need for molecular studies to elucidate tumor-specific signaling contexts and microenvironmental factors that modulate PDE10A activity. The gene discussed is PDE4A; the disease is neoplasm.